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Protein splicing is a post-translational process by which an intervening polypeptide, or
intein, catalyzes its own removal from the ﬂanking polypeptides, or exteins, concomitant
with extein ligation. Although inteins are highly abundant in the microbial world, including
within several human pathogens, they are absent in the genomes of metazoans. As protein
splicing is required to permit function of essential proteins within pathogens, inteins
represent attractive antimicrobial targets. Here we review key proteins interrupted by
inteins in pathogenic mycobacteria and fungi, exciting discoveries that provide proof of
concept that intein activity can be inhibited and that this inhibition has an effect on the host
organism’s ﬁtness, and bioanalytical methods that have been used to screen for intein
activity. We also consider potential off-target inhibition of hedgehog signaling, given the
similarity in structure and function of inteins and hedgehog autoprocessing domains.
Keywords: intein, protein splicing, novel drug target, inhibitor screening, tuberculosis, hedgehog signaling,
hedgehog autoprocessing

INTRODUCTION
Inteins are intervening polypeptides translated within host proteins that are removed through
protein splicing. Although inteins are widespread in the microbial world (Novikova et al., 2016), they
are not present in the genomes of metazoans. Given that several devastating human pathogens house
inteins within proteins essential for survival, and intein removal is considered necessary to permit
host protein function, inteins represent attractive novel drug targets (Gangopadhyay et al., 2003;
Paulus, 2003; Grainger and Beggs, 2005).
Of particular interest are mycobacterial pathogens including Mycobacterium tuberculosis,
Mycobacterium leprae, and non-tuberculosis mycobacteria (NTM), which house inteins within
important genes such as DnaB, RecA, SufB, and others (Figure 1). Prior to the recent Covid-19
pandemic, tuberculosis was the leading cause of death from an infectious agent worldwide, claiming
1.4 million deaths in 2019 (2020b). Additionally, a number of fungal pathogens such as Cryptococcus
neoformans, Cryptococcus gattii, Aspergillus fumigatus, Aspergillus nidulans, and Histoplasma
capsulatum also harbor inteins, most often in the essential spliceosomal protein Prp8 (Green
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the Prp8 protein in intein-containing fungal pathogens can
inﬂuence survival of the organism (discussed below; (Li et al.,
2021).
Here, we will discuss inteins as potential targets to selectively
kill bacterial and fungal pathogens, along with the screening
assays that could be used to test the ability of small molecules to
inhibit protein splicing. There is proof of concept evidence that
divalent cations (in particular zinc and copper), reactive oxygen,
nitrogen, and chlorine derivatives, as well as small molecules
including cisplatin and diethanolamine can act as splicing
inhibitors and impact the ﬁtness of pathogenic mycobacteria
and fungi (Gangopadhyay et al., 2003; Zhang et al., 2010; Zhang
et al., 2011; Dasari et al., 2015; Topilina et al., 2015a; Kelley et al.,
2018; Li et al., 2019; Lennon et al., 2021; Panda et al., 2021) The
discovery of drug-like molecules that can successfully inhibit the
splicing of proteins essential for survival of pathogens could
represent new treatment options. Because inteins are absent in
humans, speciﬁc intein inhibitors could have limited side effects.
The recent discovery of a small molecule inhibitor of the Prp8
intein that selectively inhibits splicing without targeting proteases
and inhibits the growth of intein-containing C. gattii and C.
neoformans is a particularly exciting breakthrough that suggests
intein inhibitors may have therapeutic beneﬁts (Li et al., 2021).
Reporter systems have been developed to detect intein activity
and could be used as screening assays for potential drug leads.
Here, we will discuss screening systems involving kanamycin
resistance, green ﬂuorescent protein (GFP), luciferase, CcdB/
CcdA, thymidylate synthetase (TS), and β-galactosidase, and
evaluate how they could be adapted to a drug screening
system (Daugelat and Jacobs, 1999; Wood et al., 1999; Adam
and Perler, 2002; Lew and Paulus, 2002; Gangopadhyay et al.,
2003; Paulus, 2003; Buskirk et al., 2004; Zeidler et al., 2004;
Bradley et al., 2005; Wong et al., 2005; Hiraga et al., 2009; Liang
et al., 2011; Zhang et al., 2011; Chan et al., 2016; Neugebauer et al.,
2017; Stevens et al., 2017; Kelley et al., 2018; Woods et al., 2020).
Additionally, inteins and the metazoan Hedgehog (Hh) family of
proteins are both HINT (Hedgehog-INTein) domain proteins
with a similar fold (Porter et al., 1996a; Porter et al., 1996b; Hall
et al., 1997). We therefore consider Hh autoprocessing, as the
cholesteriﬁcation process is similar mechanistically to protein
splicing. Although the Hh pathway is relatively inactive in adults
outside of stem cell maintenance, inhibition of the pathway could
be a problematic unintended target of a potential intein-directed
drug (Rimkus et al., 2016). On the other hand, autoprocessing
inhibitors could be useful as a cancer therapy in certain basal cell
carcinomas or medulloblastomas (Gupta et al., 2010).

FIGURE 1 | Inteins in DnaB, RecA, and SufB from pathogenic
mycobacteria. Diagram showing inteins within the DnaB, RecA, and SufB
genes of pathogenic mycobacteria. Boxes colored according to number of
inteins in gene as follows: no intein in the gene, white; one intein in the
gene, pink; two inteins in gene, maroon.

et al., 2019). C. neoformans infections pose a particular threat to
immunocompromised individuals such as those with HIV/AIDS,
with an estimated 220,000 cases of cryptococcal meningitis
occurring worldwide each year (Centers for Disease Control
and Prevention, 2020).
Inteins are found in all three domains of life, as well in viruses,
with the highest abundance within archaea and bacteria, with
about 47 and 24% of species harboring inteins, respectively
(Novikova et al., 2016). Only about 1% of the eukarya have
inteins (Novikova et al., 2016). There is considerable evidence,
although in some cases indirect, that supports the idea that
blocking protein splicing will compromise host protein
function. For example, inteins often localize to critical regions,
such as the active site, of essential proteins involved in DNA
replication, recombination, and repair (Novikova et al., 2014;
Kelley et al., 2016; Novikova et al., 2016). If the intein is within an
essential gene, as many are, inhibition of splicing should result in
killing or prevention of reproduction of the host organism.
However, as inteins have historically been studied in splicing
reporters to study activity and not within the native extein
context, there are not many examples of studies that monitor
intein inﬂuence on host protein function; this is important future
work needed in the ﬁeld. However, some direct evidence of intein
inhibition inﬂuencing host protein function does exist. One
example of the link between splicing and host protein function
is found in the intein-interrupted SufB protein of M. tuberculosis.
SufB is part of the essential SUF [Fe-S] cluster biogenesis complex
and interacts with SufC and SufD to form the SufBCD. Prior to
splicing, the SufB intein was shown to block interactions with
SufC and SufD (Huet et al., 2006). In the case of inteininterrupted RadA from the archaeon Pyrococcus horikoshii,
which harbors an intein within the ATP-coordinating P-loop,
ATPase activity is compromised prior to protein splicing
(Topilina et al., 2015b). Recently, exciting work has
demonstrated that selective inhibition of inteins interrupting
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MECHANISM OF PROTIEN SPLICING,
INTEIN VARIETY, AND POSSIBLE ROLE AS
ENVIRONMENTAL SENSORS
Small molecules that target intein action have so far been shown
to modify the active site nucleophiles of the intein active site. In
this section we brieﬂy review the mechanism of protein splicing,
and in the sections that follow we discuss in detail how these steps
are affected by known intein inhibitors.
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FIGURE 2 | Canonical mechanism of protein splicing. Protein splicing is a post-translational process where an intein (in pink) interrupts the N- and C-exteins (in
gray), which usually inactivates the extein’s native function. Step 1 is an amide-to-ester (or thioester) rearrangement of the peptide bond linking the N-extein and intein,
facilitated by the N-terminal Ser1 or Cys1 of the intein (X  O for Ser, S for Cys). Step 2 is a trans-thioesteriﬁcation reaction that transfers the N-extein from the side chain of
the ﬁrst intein residue to the side chain of the ﬁrst C-extein residue, either Ser+1, Thr+1, or Cys+1 (X  O, R  H for Ser, X  S and R  H for Cys, and X  O and R 
CH3 for Thr). Step 3 is cyclization of the C-terminal Asn (or sometimes Gln) of the intein coupled to peptide bond cleavage between the intein and C-extein. Linkage of the
exteins and excision of the intein likely restores function to the exteins (now colored blue). Finally, step four converts the ester bond linking the exteins to the amide peptide
bond and, in some cases, converts the C-terminal aminosuccinimide of the excised intein to Asn (or iso-Asn).

inteins can self-catalyze their own excision from the two ﬂanking
polypeptide sequences, or exteins, to form a mature, functional
host protein. The intein residues are numbered such that the

Key conserved residues in most inteins include an N-terminal
Cys or Ser and a C-terminal Asn. Inteins also require a Cys, Ser, or
Thr as the ﬁrst residue following the intein. Via protein splicing,

Frontiers in Molecular Biosciences | www.frontiersin.org

3

October 2021 | Volume 8 | Article 752824

Wall et al.

Intein Inhibitors as Drugs

N-terminal residue is Cys1 or Ser1 and continuing downstream,
with the ﬁrst C-extein residue as +1 and the last N-extein residue
as -1.
The canonical mechanism of protein splicing is a four-step
process (Figure 2). First, the amide bond that connects the
N-extein to the intein is rearranged to an ester or thioester,
with the N-terminal Ser or Cys of the intein as the nucleophile.
Then, transesteriﬁcation via nucleophilic attack by the ﬁrst
residue of the C-extein (Cys, Ser, or Thr) on the ester formed
in step one results in a branched intermediate, with the N-extein
moved from the side chain of the ﬁrst intein residue to the side
chain of the ﬁrst C-extein residue. These reactive nucleophiles are
the target of most intein inhibitors discussed below. It will be
essential that future lead compounds are selected that bind
selectively to inteins. Given the long history of the
development of selective protease inhibitors in therapy (Sojka
et al., 2021), and that inteins promote similar chemical steps
despite serving as their own substrate (Paulus, 2001), it seems
possible that traditional pharmacological strategies would be
useful for increasing selectivity of intein inhibitors as well.
Next, in the third step of splicing the branched ester or
thioester is resolved by asparagine cyclization coupled to
peptide bond cleavage between the intein and C-extein. The
ﬁnal step converts the ester bond linking the exteins to an
amide bond, as well as hydrolysis of the C-terminal
aminosuccinimide of the intein to Asn or iso-Asn (Mills et al.,
2014; Shah and Muir, 2014). Two alternative classes of splicing
also exist, with key differences reviewed elsewhere (Mills et al.,
2014). Irreversible off-pathway reactions can also occur, where
either the N- or C-extein is cleaved from the intein prior to
ligation. With the ability of inteins to rearrange and cleave
peptide bonds, they have been utilized extensively in
biotechnology, a topic covered in several other comprehensive
reviews (Volkmann and Mootz, 2013; Shah and Muir, 2014;
Topilina and Mills, 2014; Wood and Camarero, 2014;
Debelouchina and Muir, 2017; Sarmiento and Camarero, 2019;
Nanda et al., 2020; Romero-Casanas et al., 2020).
Inteins come in a few different varieties. Full-length inteins
contain a nested homing endonuclease (HE) domain within the
autoprocessing domain. The HE domain can facilitate intein
homing into intein-less alleles by making a double strand
break in the extein sequence that lacks the interrupting intein
gene, followed by DNA repair via homologous recombination
using the intein-containing allele as a template. Mini-inteins,
which lack the HE domain but retain the autoprocessing domain,
are also abundant. In both cases, these contiguous inteins
facilitate splicing in cis (Mills et al., 2014). In contrast, some
inteins are naturally split, with the autoprocessing domain
expressed as two separate polypeptides that must ﬁrst
assemble before protein splicing occurs in trans (Volkmann
and Iwai, 2010; Aranko et al., 2014; Li, 2015).
Although inteins don’t require any cofactor or chaperone to
splice (Mills et al., 2014), the rate and accuracy of the reaction can
be highly dependent on environmental conditions, including
redox state, pH, salt concentration, and temperature (Belfort,
2017; Lennon and Belfort, 2017). As many inteins also are mobile
genetic elements, they have traditionally been viewed as selﬁsh
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molecular parasites (Gogarten and Hilario, 2006). However,
several recent studies have provided evidence that some
inteins may play a beneﬁcial role for the host organism by
providing post-translational control of key enzymes in
response to stress (Belfort, 2017; Lennon and Belfort, 2017).

INTEIN PRESENCE IN HUMAN
PATHOGENS AND SPLICING INHIBITION
Inteins are found in the genomes of archaea, bacteria, singlecelled eukaryotes, and viruses, often within proteins required for
survival. Here we discuss the mycobacterial inteins within RecA,
DnaB, and SufB (Figure 1A), as their splicing is important for the
survival of pathogenic mycobacteria. Additionally, we consider
Prp8 inteins present in fungal pathogens including Cryptococcus
neoformans. We also discuss the chemical means by which
inhibitors of protein splicing interact with their target intein.

Mycobacterial Inteins
Mycobacteria are rod-shaped, acid-fast bacteria. Many species are
human pathogens, most notably M. tuberculosis and M. leprae, as
well as non-tuberculosis mycobacteria (NTM; i.e. mycobacteria
other than M. tuberculosis or M. leprae that cause disease in
humans). Tuberculosis remains a leading cause of death
worldwide, causing an estimated 1.4 million deaths in 2019,
with multidrug-resistant (MDR) strains becoming increasingly
common (Paulus, 2003; World Health Organization, 2020). The
World Health Organization has deemed it a priority to address
MDR tuberculosis and emerging extensively drug-resistant
tuberculosis (Kempker et al., 2015). In 2018, there were
∼209,000 new cases of leprosy, a disease that can cause
permanent damage to the skin, nerves, limbs, and eyes if
untreated. Emerging drug resistance of M. leprae has also been
detected (da Silva Rocha et al., 2012). NTM, while less common
and generally considered opportunistic pathogens, cause a range
of serious diseases and are increasing in incidence (Shamaei and
Mirsaeidi, 2021). Mycobacteria are rich in inteins, particularly in
three important genes critical for the growth of M. tuberculosis:
DnaB, SufB, and RecA (Figure 1) (Paulus, 2003). Related
mycobacterial species also have inteins present in these same
genes, yet the location and sequence can vary. If a small molecule
is able to inhibit splicing of these proteins, the mature form of the
protein will not be produced and could prevent infection.
Therefore, it is of great interest and urgency to investigate
inteins within these mycobacterial pathogens as targets for
compounds that speciﬁcally block splicing. The potential role
of inhibiting the splicing of the RecA and DnaB inteins in M.
tuberculosis has previously been reviewed (Paulus, 2003), and
these inteins have subsequently been the subject of investigation
both in vitro as well as in vivo in the mycobacteria.

Recombinase A Inhibition
One possible mode of mycobacterial inhibition is targeting the
intein in DNA Recombinase A (RecA), a protein necessary for the
repair and maintenance of DNA in mycobacteria. The M.
tuberculosis RecA intein is one of the best studied inteins, used
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FIGURE 3 | Platinum-bound Intein Structures. (A) Structure of cisplatin. (B) Structure of the M. tuberculosis RecA intein bound to two Pt(II) ions (PDB5I0A; (Chan
et al., 2016). Protein backbone in red and Pt(II) in gray. Key residues are colored and represented in space ﬁll, with Cys1 (cyan), His439 (magenta), and Cys+1 (blue)
shown. Additionally, TCEP is shown in yellow. (C) Structure of the C. gattii Prp8 intein in complex with three Pt(II) ions (PDB6MYL; (Li et al., 2019). Protein backbone in red
and Pt(II) in gray. Residues important in coordination of Pt(II) are shown as space ﬁll and colored, with Cys1 (cyan), His62 (yellow), Asp94 (orange), and His169
(magenta) shown. (D) Zoom in of M. tuberculosis RecA intein co-crystal structure bound to two Pt(II). Colored as in (B), with Cys1, His439, and Cys+1 represented as
sticks. (E) Zoom in of C. gattii Prp8 intein structure in complex with three Pt(II). Colored as in panel C, with Cys1, His62, Asp94, and His169 represented as sticks. (F)
Alignment of the M. tuberculosis RecA intein complex with two Pt(II) and the C. gattii Prp8 intein bound to three Pt(II). The M. tuberculosis RecA intein protein backbone
and Pt(II) are colored green, while the C. gattii Prp8 intein and Pt(II) are colored red.

in multiple mechanistic studies and several engineering
applications (Davis et al., 1991; Davis et al., 1992; Mills et al.,
1998; Shingledecker et al., 1998; Frischkorn et al., 2000; Saves
et al., 2000; Shingledecker et al., 2000; Hiraga et al., 2005; Van
Roey et al., 2007; Zhang et al., 2009; Du et al., 2010; Zhang et al.,
2010). It has been found that copper and zinc ions inhibit protein
splicing. Copper (II) ions inhibit splicing of a minimized RecA
intein by binding to the catalytic Cys1 and block B His residue,

Frontiers in Molecular Biosciences | www.frontiersin.org

and may have a redox effect (Zhang et al., 2010). Zinc ions can
also inhibit splicing of the full length and minimized RecA cissplicing inteins as well as a trans-splicing variant (Mills and
Paulus, 2001; Zhang et al., 2010). Zinc ions have been shown to
bind to the C-terminal active site residues of the Synechocystis sp.
PCC6803 DnaE and S. cerevisiae PI-SceI inteins (Poland et al.,
2000; Sun et al., 2005). Cisplatin inhibits the splicing of the RecA
intein by binding to Cys1, and other platinum-containing
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compounds are also able to inhibit splicing in vitro (Figure 3A)
(Zhang et al., 2011). Interestingly, over-expression of the intein
was able to reverse the growth inhibition of Mycobacterium bovis
by cisplatin, suggesting direct binding in vivo (Zhang et al., 2011).
The crystal structure of a genetically minimized M. tuberculosis
RecA intein engineered to lack its endonuclease domain (ΔHE
domain variant) in complex with cisplatin shows two dissociated
platinum ions (Pt(II)) bound to residues required for intein
catalysis (Chan et al., 2016) (Figures 3B, D). One Pt(II) binds
directly to the catalytic Cys1 residue, with the other coordinated
by the highly-conserved penultimate histidine (H439), Cys+1,
and the reducing agent (tris(2-carboxyethyl)phosphine (TCEP)
(Figures 3B, D). As these Pt(II) are coordinated directly by
residues necessary for protein splicing, the mechanism of
inhibition is relatively straightforward.
While these compounds can serve as effective inhibitors of M.
tuberculosis growth through the inhibition of protein splicing,
they do so most effectively at micromolar concentrations that
may not be suitable for in vivo applications, making them more
attractive as lead compounds (El-Kareh and Secomb, 2003).
Additionally, cisplatin has signiﬁcant side effects when used as
a chemotherapeutic due to its ability to induce DNA damage;
such side effects would likely not be tolerated for an antibiotic
except perhaps for cancer patients also infected with tuberculosis
(Dasari et al., 2015). However, this proof-of-concept inhibition
could serve to inspire the development of selective inhibitors that
target this intein.

Importantly, in addition to in vitro results, DnaBi1 splicing
inhibition by hydrogen peroxide and zinc has been observed
within M. smegmatis cells using a kanamycin intein splicing
reporter (described below) (Kelley et al., 2018; Woods et al.,
2020). These results are intriguing, both from the perspective of
testing potential antibacterial agents, but also for understanding
potential intein-based stress responses as they demonstrate that
splicing inhibition by a small molecule can prevent extein
function
in
mycobacteria.
Interestingly,
pathogenic
mycobacteria encounter and can withstand hydrogen peroxide
and metal stress when encountering mammalian innate immune
cells such as neutrophils (Zahrt and Deretic, 2002; Wagner et al.,
2005; Neyrolles et al., 2015; Weiss and Schaible, 2015; Gao et al.,
2018).

SufB Inhibition
Another intein of interest interrupts the Fe-S cluster assembly
protein B, or SufB. SufB is part of a larger protein complex that
functions to repair oxygen-labile iron-sulfur clusters under
oxidative stress. As it is highly sensitive to oxidation and
nitrosylation, this intein may help regulate SufB function.
Splicing of the SufB intein is essential for M. tuberculosis and
the assembly of the SufBCD complex, an essential system for
iron-sulfur cluster assembly in mycobacteria (Huet et al., 2006).
The intein Cys1 and Cys+1 residues have low pKa values, which
enhances their nucleophilicity and makes them sensitive to
oxidation, and thus can prevent splicing in oxidative
environments (Topilina et al., 2015a). Environments
containing oxidative elements such as hydrogen peroxide and
diethanolamine inhibit SufB splicing, resulting in precursor
accumulation or irreversible attenuation through N-terminal
cleavage. Such oxidative inhibition leads to the formation of a
disulﬁde bond between the catalytic Cys1 and Cys+1 residues,
which inhibits normal splicing activity (Topilina et al., 2015a).

DnaB Inhibition
DnaB is an essential, intein-containing helicase required for
replication. DnaB is also the most common intein-housing
gene in bacteria (Novikova et al., 2016). In mycobacterial
species housing DnaB inteins, some species contain one intein,
while others contain two inteins. Mycobacterium smegmatis is a
species with two DnaB inteins. The ﬁrst intein, DnaBi1, is a miniintein localized to the p-loop of the ATPase domain that splices
by an alternative class three mechanism (Kelley et al., 2018). The
second intein, DnaBi2, is a full-length, HE domain-containing
intein. Based on intein sequence similarity and insertion site,
DnaBi1 is similar to an intein from M. leprae, while DnaBi2 is
similar to an intein from M. tuberculosis (Kelley et al., 2018). In
M. smegmatis, DnaBi1 splicing in vitro is reversibly inhibited in
oxidizing environments induced by high micromolar
concentrations of hydrogen peroxide (Kelley et al., 2018).
DnaBi1 splicing inhibition by hydrogen peroxide results in the
formation of an intramolecular disulﬁde bond between the
catalytic nucleophile (Cys118) and a structurally-adjacent
cysteine (Cys48). Additionally, this intein binds zinc with
apparent low micromolar afﬁnity, which also reversibly blocks
splicing (Woods et al., 2020). The crystal structure of DnaBi1
bound to zinc shows the ion coordinated by the Cys118,
presumably blocking the ability of this catalytic nucleophile to
initiate the splicing reaction, as well as with V119 and Y128
(Woods et al., 2020). The M. leprae DnaB intein also has been
shown to be reversibly inhibited by zinc (Woods et al., 2020).
Conversely, DnaBi2 splices quickly without being affected by
oxidation.

Frontiers in Molecular Biosciences | www.frontiersin.org

Fungal Inteins
Several human fungal pathogens, such as Cryptococcus species,
Ajellomyces capsulatus, and Aspergillus species, contain inteins,
most often in the essential spliceosomal Prp8 protein (Green
et al., 2019). These fungal species cause pulmonary infections in
humans such as cryptococcosis, histoplasmosis, and aspergillosis,
respectively, which pose a particular threat to immunosuppressed
individuals (Bongomin et al., 2017).

Pre-mRNA Processing Factor 8 Inhibition
Pre-mRNA processing factor 8 (Prp8) is a highly conserved
nuclear protein ranging in size from 230 to 270 kDa. Prp8 has
been identiﬁed as an essential mRNA splicing factor involved
early in the mRNA splicing process (Grainger and Beggs, 2005).
Prp8 is located in the catalytic core of the spliceosome complex,
where pre-mRNA splicing occurs. In the spliceosome, Prp8 is a
component of the U5 small nuclear ribonucleoprotein (sNRP)
and U5•U4/U6 tri-sNRP and is believed to act as a cofactor in
RNA catalysis.
Over 100 Prp8 inteins have been identiﬁed. There are both
HE-containing inteins and mini-inteins, varying from 150 to over
800 residues (Butler et al., 2006). Many of the inteins occupy the
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same insertion site, with a total of seven insertion sites identiﬁed
(Green et al., 2019). Phylogenetic analysis of these inteins suggests
that the ﬁrst inteins were introduced into Prp8 over a billion years
ago, with the most recent being introduced approximately 400
million years ago. Additionally, the inteins are phylogenetically
clustered both by insertion site and by organism, suggesting that
multiple, independent invasion events occurred throughout the
evolution of this protein (Green et al., 2019).
The Prp8 intein is an exciting potential drug target given the
essential role for this protein in RNA splicing (Liu and Yang,
2004). Divalent metals such as zinc and copper ions can inhibit
the splicing of the C. neoformans intein. Though they do so in
different ways, they both function by interfering with the catalytic
N-terminal Cys1 of the intein. Copper ions reversibly oxidize the
thiol of Cys1. Zinc ions have two intein binding sites, one at the
C-terminal asparagine residue and the other at Cys1; binding at
the Asn site may be tighter (Green et al., 2019). Similarly, cisplatin
can bond with Cys1 and interfere with its activity (Li et al., 2019).
The Prp8 intein of C. neoformans can be targeted by cisplatin, as
with the M. tuberculosis RecA intein, which provides protection
to mice from infection (Li et al., 2019). The cisplatin binds
similarly at Cys1 in the Prp8 intein as it does in the RecA
intein; however, a second cisplatin that binds at a downstream
conserved active-site His residue may be more tightly coordinated
by a second ligand (Li et al., 2019). The co-crystal structure of the
C. gattii Prp8 intein with cisplatin (Li et al., 2019) has three
dissociated Pt(II) molecules, as opposed to two Pt(II) for M.
tuberculosis RecA (Figure 3C). As with M. tuberculosis RecA, one
Pt(II) is bound to the catalytic Cys1 residue. Additionally, another
Pt(II) is coordinated by the conserved penultimate histidine (H169)
similar to M. tuberculosis RecA (Figures 3C, F). Unlike M.
tuberculosis RecA, the C. gattii Prp8 intein binds a third Pt(II) at
a non-conserved histidine (His62) (Figures 3C, F). Overall
comparison with M. tuberculosis RecA shows considerable
similarities in the overall alignment of the two structures
(Figure 3D). In particular, the coordination of Pt(II) at both Nand C-terminal residues required for intein activity (Figure 3D).
Furthermore, as with M. smegmatis DnaBi1(Woods et al., 2020), the
inhibitor is bound directly by residues strictly required for protein
splicing, explaining the mechanism of inhibition.
Recently, a landmark study on the use of inhibitors that target
Prp8 protein splicing as a strategy to selectively kill pathogenic
fungi was published (Li et al., 2021). In this work, small molecules
identiﬁed from a library that inhibit the splicing of the Prp8 intein
in vitro, in E. coli and in C. neoformans, reduced the growth of
intein-containing C. neoformans and C. gattii, but not of the
intein-less Candida albicans (Li et al., 2021). The inhibition is
likely via a covalent modiﬁcation to Cys1 of the Prp8 intein. This
is a particularly compelling development in the exploration of
inteins as novel antimicrobials, strongly supporting the viability
of this strategy.

to screen for selective inhibitors would be high-throughput and
could assay against inhibition of off-site targets or general
cytotoxicity. Although many existing drugs are covalent
mechanism-based inhibitors, it would be important to select
for drugs speciﬁc to the intein rather than simply to a reactive
Cys or Ser to prevent off-site toxicity. Selectable systems have
been employed in directed evolution experiments to tune intein
function, and split exteins have been used as reporters for splicing
activity (Shah and Stevens, 2020). Several of these systems could
be repurposed for drug screening. Below, we describe systems
based on kanamycin resistance, GFP ﬂuorescence and luciferase
activity, CcdB/CcdA activity, thymidylate aynthase activity, and
β-galactosidase colorimetry.

Aminoglycoside Phosphotransferase
One method used to evaluate intein splicing and therefore serve
as a screen for small molecule inhibitors is the use of the
kanamycin resistance protein interrupted by an intein.
Kanamycin A is an aminoglycoside antibiotic that inhibits
translation and is widely used in molecular biology. Bacterial
cells able to grow on media containing the antibiotic require a
mature
aminoglycoside
phosphotransferase
(KanR).
Experimental cells are transformed to contain the KanR gene
interrupted by an intein. Typically, the positive control is the
uninterrupted KanR gene without an intein, as no splicing is
required to produce resistance to kanamycin. When designing a
kanamycin intein splicing reporter for the purpose of evaluating
splicing inhibitors, it is crucial that protein splicing be required to
provide resistance (Figure 4A). Somewhat surprisingly, when
splicing active and inactive versions of the M. smegmatis DnaBi1
intein were inserted at 16 positions throughout the KanR protein,
ﬁve displayed splicing-dependent resistance, eight displayed
splicing-independent resistance, and three provided no
resistance (Woods et al., 2020). Therefore, to ensure that
kanamycin resistance cannot be provided by a KanR protein
that is still interrupted by an intein, which would result in false
positives when selecting for intein activity or potentially false
negatives when searching for splicing inhibitors, a splicing
inactive intein must also be tested at the same position within
the KanR gene (Kelley et al., 2018; Woods et al., 2020; Woods
et al., 2021). As expected, proximity to the active site correlated
with the requirement of splicing for resistance, with all M.
smegmatis DnaBi1-KanR splicing-dependent resistance fusions
were within 14 residues and 16 Å of the active site (Woods et al.,
2020). In addition to ensuring that the inhibition of splicing
would lead to kanamycin sensitivity by blocking splicing, the
potential splicing inhibitor must be tested for cytotoxicity
independent of splicing and lack of kanamycin resistance
(Kelley et al., 2018; Woods et al., 2020) (Figure 4B). Ideally,
the intein-KanR fusion should display reduced survival relative to
an uninterrupted KanR in the presence of both a potential
inhibitor and kanamycin (Figure 4B).
A signiﬁcant advantage of the kanamycin intein splicing
reporter is that it has been shown that it can be used in the
native intein host, in this case M. smegmatis, so long as the host is
sensitive to kanamycin. This system has been used in M.
smegmatis to detect inhibition of the DnaBi1 intein by

SCREENING FOR INTEIN ACTIVITY
Selective small molecule inhibitors of protein splicing could be
effective tools against several human pathogens. Ideally, a system
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FIGURE 4 | Kanamycin Intein Splicing Reporter. For a splicing-dependent reporter, KanR interrupted with a catalytically active intein is resistant to kanamycin (A),
while KanR interrupted with a catalytically inactive intein that cannot undergo splicing is not resistant to kanamycin (B). In (C), we show the experimental design to test the
speciﬁc inhibition of protein splicing using a kanamycin-intein splicing reporter. In addition to cells containing the splicing-dependent KanR-intein fusion plasmid, control
plasmids include KanR without an intein, a splicing inactive KanR-intein fusion, and kanamycin cells lacking a KanR-containing plasmid. In this design, serial
dilutions of cells should be grown under four conditions: 1) without kanamycin and without splicing inhibitor; 2) without kanamycin and with splicing inhibitor; 3) with
kanamycin and without splicing inhibitor; and 4) with kanamycin and with splicing inhibitor. Growth of the kanamycin sensitive and splicing inactive KanR-intein fusion
strains should only occur in the absence kanamycin. Presence of the splicing inhibitor in the absence of kanamycin should not decrease growth of any strain. If inhibition
of protein splicing occurs, the splicing-dependent KanR-intein fusion will display reduced survival compared to KanR without an intein. Interrupted, inactive exteins are
colored gray, inteins are colored pink if active and gray if inactivated by mutation, and active KanR is colored blue.

Frontiers in Molecular Biosciences | www.frontiersin.org

8

October 2021 | Volume 8 | Article 752824

Wall et al.

Intein Inhibitors as Drugs

FIGURE 5 | GFP-intein fusion ﬂuorescence reporter. The GFP-intein fusion is expressed as inclusion bodies (as indicated by overlapping diagrams), denatured by
urea, and renatured in the presence of Zn2+ to prevent splicing. To allow splicing to proceed, EDTA is added to chelate Zn2+, yielding ﬂuorescent GFP and the excised
intein. In the presence of a splicing inhibitor of interest, splicing is blocked, leading to no increase in ﬂuorescence. Exteins are colored gray and the intein is colored pink/
red. Post-splicing GFP is colored green. Zn2+ is colored black and inhibitor purple. PDBs 2B3P (Superfolder GFP) and 2IN9 (M. tuberculosis RecA mini intein) were
used to create this image (Pedelacq et al., 2006; Van Roey et al., 2007).

hydrogen peroxide and zinc (Kelley et al., 2018; Woods et al.,
2020; Woods et al., 2021), both stressors mycobacteria can
encounter during challenge from the innate immune system
(Zahrt and Deretic, 2002; Wagner et al., 2005; Neyrolles et al.,
2015; Weiss and Schaible, 2015; Gao et al., 2018). Although M.
smegmatis is generally non-pathogenic, and results may not
translate exactly to mycobacteria that harbor conserved inteins
like M. tuberculosis and M. leprae, it is useful as proxy for these
pathogens. Importantly, this general approach could be adapted
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to any intein-containing pathogen, as long as the pathogen is
sensitive to kanamycin and appropriate expression vectors are
available. On the other hand, one disadvantage to this screening
system is the possibility of missing a lead compound that could
serve as an inhibitor because it cannot penetrate the cells.
Additionally, adaptation of the system to a high-throughput
liquid culture format, rather than agar plates, could
signiﬁcantly increase the speed at which potential inhibitors
can be tested.
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It should be noted that the KanR-intein fusion design has been
used in applications other than to search for inhibitors. One of the
ﬁrst uses of a kanamycin screening system was to identify open
reading frames of the pathogen Haemophilus inﬂuenzae
(Daugelat and Jacobs, 1999). In another application, a
kanamycin selection system was used to make splicing
conditional on addition of a small molecule, 4hydroxytamoxifen (Buskirk et al., 2004). Finally, a KanR
system has been used to improve splicing of the naturally split
Nostoc punctiforme DnaE intein through directed evolution
(Lockless and Muir, 2009).

was split between residues 229 and 230 with the Prp8 intein from
C. gattii (Li et al., 2019). The fusion protein was isolated at pH 9,
where splicing was inefﬁcient, and then incubated with or without
inhibitor at pH 8, with a decrease in ﬂuorescence measuring
splicing inhibition, in this case with cisplatin (Li et al., 2019). Both
this split luciferase system, as well as a split GFP system, was used
to measure the splicing of the C. neoformans Prp8 intein (Li et al.,
2021). GFP ﬂuorescence was dependent on TCEP, showing that
splicing and thus ﬂuorescence was dependent on the intein active
site Cys being present as a free thiol. The system also allowed for
discovery of small molecule inhibitors of the intein, as discussed
above (Li et al., 2021).

Green Fluorescence Protein and Luciferase
CcdA/B Toxin-Antitoxin

It is possible to screen for intein activity by making the
ﬂuorescence of green ﬂuorescent protein (GFP) conditional on
protein splicing either in cis and in trans. GFP ﬂuorescence is
useful for small molecule inhibitor discovery as it is amenable to
high throughput screening and does not require potential lead
compounds to penetrate a cell. The full-length M. tuberculosis
RecA intein was used to interrupt GFP after residue 129, based on
the observation that peptide insertions adjacent to this residue
result in GFP expression into inclusion bodies in E. coli (Figure 5)
(Gangopadhyay et al., 2003). An N-terminal His tag allows for
puriﬁcation of intein-interrupted GFP via immobilized metal
afﬁnity chromatography, followed by denaturation in 8M urea
and renaturation into a folding buffer. The addition of zinc ions
during refolding prevents intein activity as measured by GFP
ﬂuorescence, and this inhibition can be readily reversed by the
addition of EDTA (Gangopadhyay et al., 2003). In vitro screening
may be facilitated by mixing potential inhibitors during the
refolding process. GFP ﬂuorescence was used in a directed
evolution experiment to measure splicing efﬁciency of evolved
versions of the M. tuberculosis RecA intein (Yuen et al., 2006).
The Synechocystis sp. PCC6803 DnaE split intein was used to
reconstitute GFP in an assay to detect protein-protein
interactions; the intein was reported to facilitate some GFP
ﬂuorescence without other interacting partners driving the
association and hence this could serve as a means to select
inhibitors for DnaE split intein reassociation (Ozawa et al., 2001).
GFP ﬂuorescence as a screening system was used to explore
the effect of platinum-containing compounds on the splicing of a
minimized M. tuberculosis RecA intein (Chan et al., 2016). These
compounds, including cisplatin, Pttfbz, Zeise’s salt, and
phenanthriplatin, were added to a stabilized precursor GFPRecA fusion protein in concentrations up to 80 µM. Once
splicing was initiated with EDTA, the resulting ﬂuorescence
was observed, and it was found that increased concentrations
of the Pt-containing compounds led to decreased ﬂuorescence,
suggesting that the compounds could successfully inhibit RecA
protein splicing (Chan et al., 2016). This supported previous work
suggesting that cisplatin can be toxic to M. tuberculosis, with
intein over-expression decreasing the toxicity, indicating direct
binding of the intein to cisplatin in vivo (Zhang et al., 2011). GFP
screening also was used to investigate the inﬂuence of mutations
of non-catalytic sites on RecA intein activity (Hiraga et al., 2009).
Using a similar design by which interruption with an intein
blocks reporter function, the luciferase from Renilla reniformis
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Another in-cell screening system utilizes the E. coli toxin CcdB,
which targets the topoisomerase GyrA (Bernard and Couturier,
1992). The full length M. tuberculosis RecA intein was used to
interrupt CcdB on both a low and high copy number plasmid,
such that cell growth is coupled to splicing inhibition. The inteinccdB fusion was used to determine splicing efﬁciency as
modulated by mutations to ﬂanking extein residues (Lew and
Paulus, 2002). Using plasmids with variable copy number and/or
expression levels using a tunable promoter could vary the
stringency used in different rounds of small molecule
screening. A similar screening system utilizes the E. coli
antitoxin CcdA, which acts as the CcdB antitoxin, forming an
inactivated complex. In this method, an intein-less CcdB is
expressed by an E. coli strain, and the intein is instead
inserted into the CcdA protein in a region that directly
interacts with CcdB, allowing CcdA to only inactivate CcdB if
protein splicing occurs. This system worked with the cis-splicing
Nostoc punctiforme DnaB intein and the naturally split transsplicing cyanobacterial gp41-1 intein (Beyer and Iwai, 2019). The
CcdA system can serve as an in vivo counter-selection method for
the CcdB model, as effective intein inhibitors would cause cell
death rather than permit cell growth.

Thymidylate Synthase
An intein-thymidylate synthase (TS) fusion represents another in
vivo system that may be used to monitor protein splicing. E. coli
in the absence of thymidine in media cannot grow without
functional TS; therefore, TS can serve as an indicator of
splicing when it is interrupted by an intein (Wood et al.,
1999). E. coli that lack their native TS can be transformed
with a plasmid coding for TS with an intein inserted. If the
transformed bacteria are grown in thymidine-lacking media,
growth will not occur without protein splicing, as the
unspliced intein-TS fusion protein is nonfunctional
(Figure 6A). This system conveniently has a natural negative
control, as growth in thymidine-rich media would not be
splicing-dependent, and an inhibitor should show little effect
on cell growth if its activity is intein-speciﬁc. Another useful
aspect of this system is that N-terminal fusions inactivate TS
(Figure 6B). Therefore, intein-mediated splicing and C-terminal
cleavage can also be monitored by this system (Figure 6C) (Wood
et al., 1999). This system was used to isolate an activating splicing
mutant of a minimized version of the M. tuberculosis RecA intein
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FIGURE 6 | Thymidylate Synthase (TS) selection/counter-selection system. (A) Splicing reporter where TS is interrupted by an intein and protein splicing must
occur to yield a functional enzyme. (B) Cleavage reporter where a variant intein that can only undergo C-terminal cleavage interrupts an N-extein of maltose-binding
protein (MBP) and a C-extein of TS. Because N-terminal fusions disrupt TS activity, C-terminal cleavage of the intein must occur to yield a functional enzyme. (C) TS
activity is required for growth to occur in thymidine-lacking media (Thy-). (D) In the counter-selection model, functional TS inhibits growth in the presence of
trimethoprim (TMP). Exteins are colored gray, intein pink, MBP green, and active TS blue.

and to select a mutant that facilitates pH-dependent C-terminal
cleavage (Wood et al., 1999).
The TS system also has been used to design an intein-based
system by which the miniaturized M. tuberculosis RecA intein
was interrupted by a thyroid hormone receptor, making splicing
and TS activity sensitive to the addition of thyroid hormone
(Skretas and Wood, 2005). A TS-splicing system, in a modiﬁed
format, also has been used to screen libraries of de novo protein
sequences for frameshifts or stop codons. Insertion of gene
sequences upstream of the intein-TS fusion that are out of
frame prevent expression of the intein-TS fusion and hence
growth on thymidine-free media (Bradley et al., 2005).
Screening for intein activity by conditional TS activity also has
the advantage of a counter-selection system, using trimethoprim
(TMP) (Figure 6D) (Wong et al., 2005). TMP inhibits
dihydrofolate reductase and therefore prevents the production
of tetrahydrofolate (THF). If TS is active, THF is depleted. In
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thymidine-rich media, the cells don’t require active TS for
thymidine and can grow, but active TS is toxic in the presence
of TMP. This model of counter selection allows for screening of
inhibitors of splicing or C-terminal cleavage.

β-galactosidase

β-galactosidase is a widely employed E. coli reporter. Functional
β-galactosidase cleaves X-gal into 5-bromo-4-chloro-3hydroxyindole, which spontaneously dimerizes and oxidizes to
form the bright blue pigment 5,5’-dibromo-4,4’-dichloro-indigo.
Active β-galactosidase in E. coli results in blue colonies, whereas
inactive β-galactosidase results in white colonies. In a commonly
used technique β-galactosidase is split, and insertions into the
α-peptide, which complements enzyme activity, can be used for
blue-white screening (Green and Sambrook, 2019). If colonies are
white, an insertion has been made in the α-peptide and
β-galactosidase is nonfunctional. Additionally, β-galactosidase
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test the inﬂuence of active site mutations (Neugebauer et al.,
2017). This time-tested assay could serve as a powerful way to
screen for in vivo intein inhibition in a scalable model that does
not rely on cytotoxicity as an output, as well as provide the option
for quantitative measurements via Miller Units (Figure 7C).

HEDGEHOG AUTOPROCESSING AND
OFF-TARGET CONSIDERATIONS
The Hedgehog (Hh) signaling pathway is required for cell
differentiation and proliferation during animal development.
In adults, Hh signaling is mostly turned off but is involved in
adult tissue regeneration and stem cell maintenance. Abnormal
Hh activation is implicated in many types of cancer (Sigafoos
et al., 2021). Because the structure and mechanism of inteins and
the Hh family of proteins share so many features (Hall et al.,
1997), it is important to consider the potential effect of intein
inhibitors on Hh signaling, including Hh autoprocessing.
Hh ligands are produced from a unique self-catalyzed process,
called Hh autoprocessing. The Hh ligand is not a direct product of
translation; rather, it comes from an Hh precursor protein, which
is subject to two post-translational modiﬁcations:
cholesterylation at the C-terminus of the Hh ligand during Hh
autoprocessing, and subsequently palmitoylation at the
N-terminus (Callahan and Wang, 2015). Due to increased
hydrophobicity, these post-translational modiﬁcations help
establish the Hh gradients necessary for Hh signaling in
development, and abnormalities in the post-translational
modiﬁcations can lead to severe congenital diseases, including
holoprosencephaly (HPE) (Roessler et al., 1997; Incardona and
Roelink, 2000).
The Hh precursor consists of two domains: the N-terminal
domain, HhN, and the C-terminal domain, HhC. HhN is the
signaling domain, or Hh ligand. The HhC is the autoprocessing
domain, consisting of the HINT domain and the sterolrecognition region (SRR). The HINT region shares many
structural and functional similarities to the protein splicing of
inteins (Xie et al., 2016). Hh autoprocessing consists of two steps
(Figure 8). The ﬁrst step is an N-S acyl shift, an amide to thioester
rearrangement of the peptide bond linking HhN and HhC,
identical to the ﬁrst step of protein splicing. The second step
is a transesteriﬁcation using cholesterol as the nucleophile,
resulting in cleavage of the thioester bond linking HhN and
HhC and the cholesterylation of the C-terminus of HhN
(Callahan and Wang, 2015; Xie et al., 2016). The precise
means by which the SRR binds and activates cholesterol is
unclear, but it is possible that the SRR may tether the entire
Hh to a cholesterol-rich membrane, facilitating the recruitment of
the cholesterol directly to the HhN active site, that it extracts
cholesterol from the membrane and moves it to the Hh active site,
or that it provides a hydrophobic conduit (Maﬁ et al., 2021). Next,
the cholesterylated HhN is further lipidized by the hedgehog acyl
transferase, which covalently links palmitic acid to the HhN
N-terminus (Pepinsky et al., 1998). Once both lipids are
bonded to HhN, the newly formed Hh ligand can be properly
transported and used for downstream signaling. The cleaved

FIGURE 7 | . β-galactosidase (lacZ) splicing and cleavage reporters. (A)
Splicing reporter where β-galactosidase/LacZ is interrupted by an intein and
protein splicing must occur to yield a functional enzyme. (B) Splicing reporter
where β-galactosidase/LacZ is split and the α-peptide, which
complements enzyme activity, is interrupted by an intein and protein splicing
must occur for the α-peptide to restore β-galactosidase/LacZ activity. (C)
β-galactosidase/LacZ activity can be detected in colonies, indicated by blue
color, or quantitatively measured in cell lysates by Miller Units (yellow color).
Exteins are colored gray, intein pink, and active β-galactosidase/LacZ blue.

activity can be assayed quantitatively from cell lysates by
measuring Miller Units, another colorimetric assay that
measures the conversion of o-nitrophenyl-β-D-galactoside to
galactose and o-nitrophenol, the latter which can be measured
spectroscopically (Smale, 2010). Modiﬁed blue-white screening
has been used by interrupting E. coli β-galactosidase with an
intein. For example, this was used to analyze the splicing activity
of an estrogen-sensitive version of the S. cerevisiae vacuolar
ATPase (VMA) intein in the presence of estrogen or synthetic
analogs (Figure 7A). Rather than inhibition, this system tested for
activation of the intein (Liang et al., 2011).
Another version of blue-white screening was used to identify
active intein mutants and characterize the conditions favorable to
splicing. Modiﬁed and artiﬁcially split versions of the
Synechocystis sp. PCC6803 DnaB intein were inserted into two
different sites in the β-galactosidase α-peptide whereby
complementation of enzyme activity was dependent on
splicing (Figure 7B). Subsequently, this system were used to
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FIGURE 8 | Mechanism of hedgehog autoprocessing. The hedgehog precursor protein is comprised of the signaling domain (HhN, gray) and the autoprocessing
domain (HhC in pink, comprised of a HINT domain (Hedgehog-INTein) and a C-terminal sterol recognition region (SRR). The ﬁrst step of the autoprocessing is similar to
that of protein splicing: conversion of the peptide bond linking the HhN to HhC from an amide to thioester via the N-terminal Cys of the HhC domain. Then, in place of the
trans-thioesteriﬁcation via the C-extein that occurs in protein splicing, a cholesterol molecule, bound to the SRR, facilitates an addition/elimination reaction at the
newly formed thioester, resulting in cholesterylation of HhN concomitant to bond cleavage between HhN and HhC. The HhN (now blue) is further modiﬁed by N-terminal
palmitoylation prior to its function in signaling.

HhC, on the other hand, is likely degraded by the proteosome
(Briscoe and Thérond, 2013).
A mature N-terminally palmitoylated and C-terminally
cholesterylated Hh ligand is then secreted into the extracellular
space with the help of Dispatched-1 and Scube2. Once in the
extracellular space, Scube2 proteins act as chaperones and bind to
the Hh ligand during its transfer from producing to receiving
cells. The ligand binds to Patched-1 on the receiving cell surface,
which then releases its inhibition of smoothened (SMO),
activating glioma-associated oncogene homolog (GLI)
transcription factors to trigger subsequent signaling events
such as development and patterning (Qi and Li, 2020).
As both inteins and Hh family proteins have HINT domains,
they share conserved residues. The ﬁrst is the catalytic Cys1
residue, the nucleophile in the amide-thioester rearrangement.
Two other conserved residues, a Thr and His in the TXXH motif
of “block B” of the HINT domain, catalyze the thioester
formation during autoprocessing. Two additional conserved
HhC residues, an Asp and a downstream Cys (D46 in C143
Drosophila HINT), do not have direct homologous residues in
intein sequences. The downstream Cys is capable of forming an
internal disulﬁde bond with Cys1, suggesting a role in proper
folding (Chen et al., 2011). The conserved Asp likely coordinates
the binding of cholesterol to the SRR with the ﬁrst step of
autoprocessing, and activates the hydroxyl group of cholesterol
to attack the thioester (Hall et al., 1997; Xie et al., 2016).
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Surprisingly, substitution of this Asp with His, a nominal
charge reversal substitution (D46H in Drosophila HINT), can
allow for a wider array of molecules, including coprostanol and
epicoprostanol, to serve as the sterol substrate (Zhao et al., 2019).
This is likely due to the more favorable, less spatially restrictive
electrostatic stabilization of transition state provided by the H46
variant.
Hh autoprocessing can be inhibited by zinc and, similarly to
protein splicing, zinc ions can bind to residues vital for
autoprocessing to inhibit the function. For Drosophila Hh,
micromolar zinc concentrations can inhibit autoprocessing,
potentially by coordinating Cys1 and the essential His and
Asp residues. Prostate, lung, and ovarian cancers are partially
characterized by high levels of Hh ligand and low zinc levels, and
zinc inhibition of autoprocessing might suggest a link between
these observations (Xie et al., 2016). Given that inteins and Hh
proteins share zinc-mediated inhibition, some intein-inhibitors
may also inhibit Hh autoprocessing, and selective intein
inhibitors may be useful. Hh autoprocessing also can be
inhibited by selective alkylation of the downstream Cys
residue. As measured by a FRET-based cholesterolysis assay,
novel compound ST044643 covalently modiﬁes the Cys to
inhibit cholersterolysis (Owen et al., 2015). Compounds that
activate hydrolysis of the scissile peptide bond between the
signaling domain and the autoprocessing domain have
recently been described (Smith et al., 2020). These so-called
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HhC activator compounds redirect the cholesterylation reaction
toward hydrolysis, even in the presence of sterol, in a noncovalent mechanism termed paracatalysis. This is exciting, as
it suggests that similar paracatalytic compounds may be
discovered for inteins, diverting splicing to side reactions that
prevent ligation of the ﬂanking exteins. However, this also
cautions us that such compounds might be cross-reactive with
Hh autoprocessing domains.
Because of the shared HINT domain between intein and
Hh autoprocessing, it is important to test if an intein inhibitor
is also an inhibitor for Hh autoprocessing. Then, intein
inhibitors can be classiﬁed into two categories: selective
intein inhibitors that do not affect Hh autoprocessing and
nonselective inhibitors, such as Zn ion, that inhibit both intein
splicing and Hh autoprocessing. Both types of inhibitors may
be useful in clinical settings. For example, if a patient has both
Hh ligand-dependent cancer and tuberculosis infection, a
nonselective intein inhibitor may be effective against both the
cancer and infection, respectively. By inhibiting Hh
autoprocessing, the drug will reduce Hh ligand, curbing
cancer growth. By inhibiting intein splicing, key DNA
enzymes in M. tuberculosis, such as the intein-interrupted
RecA, cannot be generated, curbing the tuberculosis
infection.
Indeed,
many
cancer
patients
are
immunocompromised and more susceptible to TB
infection, thus such a clinical scenario can indeed arise.
Selective inhibitors will be useful for cases where active Hh
signaling needs to be preserved during the application of
intein inhibitor, for example in treating TB during pregnancy.
To distinguish between selective intein inhibitors and those
that also target Hh autoprocessing, screens could be designed
in tandem. For example, by combining one of the intein
activity reporters described above with a FRET-based
cholesterolysis assay for Hh activity (Owen et al., 2015),
selective intein inhibitors could be identiﬁed.

proteins, provides a potential avenue to kill these
devastating pathogens. Decades of intein research has
demonstrated that protein splicing can be modulated by
numerous environmental factors (Belfort, 2017; Lennon
and Belfort, 2017). Given the overall abundance of inteins
in the microbial world, presence of inteins in essential genes
of bacterial and fungal pathogens, and absence of inteins in
metazoans, inteins represent attractive drug targets. While
the FDA-approved chemotherapeutic cisplatin has been
shown to block protein splicing of inteins from both M.
tuberculosis and C. neoformans (Zhang et al., 2011; Chan
et al., 2016; Li et al., 2019), it may not be an appropriate
treatment option given off-target DNA damage. However,
cisplatin and other splicing inhibitors (Li et al., 2021)
demonstrate the proof of concept that splicing inhibitors
can be used to kill pathogens and may serve as lead
compounds to future drug development. As tuberculosis is
typically the leading cause of death worldwide from infectious
disease, and multidrug-resistance is becoming increasingly
common, there is an urgent need for novel drug targets. The
next stages of the development of intein inhibitors as drugs
include the validation of inteins as important drug targets by
clear demonstration that protein splicing is essential to
pathogen survival and/or growth, and attention to
developing more complex inhibitors that are speciﬁc to
inteins rather than closely related hedgehog proteins or
somewhat related enzymes such as proteases with reactive
active site nucleophiles.
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